IGEA S.p.A.
Samantha Tinsdale is an experienced professional with a strong background in medical devices and project management. Currently serving as Country Manager for the UK and Ireland at IGEA SpA since October 2016, Samantha previously held various roles at Johnson & Johnson, including Product Specialist and Professional Education Coordinator. Samantha's expertise encompasses event and project management, customer relations, and internal communications. Samantha's career began with administrative roles at DePuy Synthes and TNT Post UK, where Samantha managed project implementation and provided support to senior marketing directors. Educational background includes attendance at Loreto Convent Grammar School for Girls.
This person is not in any teams
This person is not in any offices
IGEA S.p.A.
IGEA studies the clinical application of physical stimuli to biological systems. Our mission is to improve patients’ quality of life by developing and producing innovative, effective and safe therapeutic systems for clinical practice. IGEA develops biophysical treatments in two main areas: - Orthopedics: to improve bone healing and joint preservation. - Oncology: to treat cancer. IGEA is the world leading company for Electrochemotherapy, a minimally invasive treatment combining a low dose of a chemotherapy drug and electrical pulses (electroporation) applied directly to the cancer cells using specific multiple or individual electrodes. Cliniporator® and Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.